ID POLG_FMDVT Reviewed; 2327 AA. AC P15072; Q6PMY1; Q84755; Q84756; Q84757; Q84758; DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot. DT 29-MAY-2013, sequence version 2. DT 24-JAN-2024, entry version 173. DE RecName: Full=Genome polyprotein; DE Contains: DE RecName: Full=Leader protease; DE Short=Lpro; DE EC=3.4.22.46; DE Contains: DE RecName: Full=Capsid protein VP0; DE AltName: Full=VP4-VP2; DE Contains: DE RecName: Full=Capsid protein VP4; DE AltName: Full=P1A; DE AltName: Full=Virion protein 4; DE Contains: DE RecName: Full=Capsid protein VP2; DE AltName: Full=P1B; DE AltName: Full=Virion protein 2; DE Contains: DE RecName: Full=Capsid protein VP3; DE AltName: Full=P1C; DE AltName: Full=Virion protein 3; DE Contains: DE RecName: Full=Capsid protein VP1; DE AltName: Full=P1D; DE AltName: Full=Virion protein 1; DE Contains: DE RecName: Full=Protein 2A; DE Short=P2A; DE AltName: Full=P52; DE Contains: DE RecName: Full=Protein 2B; DE Short=P2B; DE Contains: DE RecName: Full=Protein 2C; DE Short=P2C; DE EC=3.6.1.15; DE Contains: DE RecName: Full=Protein 3A; DE Short=P3A; DE Contains: DE RecName: Full=Protein 3B-1; DE Short=P3B-1; DE AltName: Full=Genome-linked protein VPg1; DE Contains: DE RecName: Full=Protein 3B-2; DE Short=P3B-2; DE AltName: Full=Genome-linked protein VPg2; DE Contains: DE RecName: Full=Protein 3B-3; DE Short=P3B-3; DE AltName: Full=Genome-linked protein VPg3; DE Contains: DE RecName: Full=Protease 3C; DE EC=3.4.22.28; DE AltName: Full=Picornain 3C; DE Short=P3C; DE AltName: Full=Protease P20B; DE Contains: DE RecName: Full=RNA-directed RNA polymerase 3D-POL; DE Short=P3D-POL; DE EC=2.7.7.48; DE AltName: Full=P56A; OS Foot-and-mouth disease virus (isolate -/Germany/C1Oberbayen/1960 serotype OS C) (FMDV). OC Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes; OC Picornavirales; Picornaviridae; Caphthovirinae; Aphthovirus; OC Foot-and-mouth disease virus. OX NCBI_TaxID=12121; OH NCBI_TaxID=9913; Bos taurus (Bovine). OH NCBI_TaxID=9925; Capra hircus (Goat). OH NCBI_TaxID=9850; Cervidae (Deer). OH NCBI_TaxID=9363; Erinaceidae (hedgehogs). OH NCBI_TaxID=9785; Loxodonta africana (African elephant). OH NCBI_TaxID=9940; Ovis aries (Sheep). OH NCBI_TaxID=10116; Rattus norvegicus (Rat). OH NCBI_TaxID=9823; Sus scrofa (Pig). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA]. RX PubMed=15858032; DOI=10.1128/jvi.79.10.6487-6504.2005; RA Carrillo C., Tulman E.R., Delhon G., Lu Z., Carreno A., Vagnozzi A., RA Kutish G.F., Rock D.L.; RT "Comparative genomics of foot-and-mouth disease virus."; RL J. Virol. 79:6487-6504(2005). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1-1011. RX PubMed=6316275; DOI=10.1093/nar/11.22.7873; RA Beck E., Forss S., Strebel K., Cattaneo R., Feil G.; RT "Structure of the FMDV translation initiation site and of the structural RT proteins."; RL Nucleic Acids Res. 11:7873-7885(1983). RN [3] RP ALTERNATIVE INITIATION. RX PubMed=3033601; DOI=10.1093/nar/15.8.3305; RA Sangar D.V., Newton S.E., Rowlands D.J., Clarke B.E.; RT "All foot and mouth disease virus serotypes initiate protein synthesis at RT two separate AUGs."; RL Nucleic Acids Res. 15:3305-3315(1987). RN [4] {ECO:0007744|PDB:1FMD} RP X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 287-504 AND 505-723. RX PubMed=8081743; DOI=10.1016/s0969-2126(00)00014-9; RA Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., RA Fry E., Abu-Ghazaleh R., King A., Newman J.; RT "The structure and antigenicity of a type C foot-and-mouth disease virus."; RL Structure 2:123-139(1994). RN [5] {ECO:0007744|PDB:1EJO} RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 859-873. RX PubMed=10811933; DOI=10.1099/0022-1317-81-6-1495; RA Ochoa W.F., Kalko S.G., Mateu M.G., Gomes P., Andreu D., Domingo E., RA Fita I., Verdaguer N.; RT "A multiply substituted G-H loop from foot-and-mouth disease virus in RT complex with a neutralizing antibody: a role for water molecules."; RL J. Gen. Virol. 81:1495-1505(2000). CC -!- FUNCTION: [Leader protease]: Autocatalytically cleaves itself from the CC polyprotein at the L/VP0 junction. Also cleaves the host translation CC initiation factors EIF4G1 and EIF4G3, in order to shut off the capped CC cellular mRNA transcription. Plays a role in counteracting host innate CC antiviral response using diverse mechanisms. Possesses a deubiquitinase CC activity acting on both 'Lys-48' and 'Lys-63'-linked polyubiquitin CC chains. In turn, inhibits the ubiquitination and subsequent activation CC of key signaling molecules of type I IFN response such as host RIGI, CC TBK1, TRAF3 and TRAF6. Inhibits host NF-kappa-B activity by inducing a CC decrease in RELA mRNA levels. Cleaves a peptide bond in the C-terminus CC of host ISG15, resulting in the damaging of this modifier that can no CC longer be attached to target proteins. Also cleaves host G3BP1 and CC G3BP2 in order to inhibit cytoplasmic stress granules assembly. CC {ECO:0000250|UniProtKB:P03305, ECO:0000250|UniProtKB:P03308}. CC -!- FUNCTION: [Capsid protein VP4]: Lies on the inner surface of the capsid CC shell. After binding to the host receptor, the capsid undergoes CC conformational changes. Capsid protein VP4 is released, capsid protein CC VP1 N-terminus is externalized, and together, they shape a pore in the CC host membrane through which the viral genome is translocated into the CC host cell cytoplasm. After genome has been released, the channel CC shrinks. {ECO:0000250|UniProtKB:P03300}. CC -!- FUNCTION: [Capsid protein VP2]: Forms an icosahedral capsid of pseudo CC T=3 symmetry with capsid proteins VP1 and VP3. The capsid is composed CC of 60 copies of each capsid protein organized in the form of twelve CC pentamers and encloses the viral positive strand RNA genome. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Capsid protein VP1]: Forms an icosahedral capsid of pseudo CC T=3 symmetry with capsid proteins VP2 and VP3. The capsid is composed CC of 60 copies of each capsid protein organized in the form of twelve CC pentamers and encloses the viral positive strand RNA genome. Mediates CC cell entry by attachment to an integrin receptor, usually host CC ITGAV/ITGB6. In addition, targets host MAVS to suppress type I IFN CC pathway. {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Capsid protein VP3]: Forms an icosahedral capsid of pseudo CC T=3 symmetry with capsid proteins VP0 and VP3. The capsid is composed CC of 60 copies of each capsid protein organized in the form of twelve CC pentamers and encloses the viral positive strand RNA genome. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 2A]: Mediates self-processing of the polyprotein by CC a translational effect termed 'ribosome skipping'. Mechanistically, 2A- CC mediated cleavage occurs between the C-terminal glycine and the proline CC of the downstream protein 2B. In the case of foot-and-mouth disease CC virus, the 2A oligopeptide is post-translationally 'trimmed' from the CC C-terminus of the upstream protein 1D by 3C proteinase. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 2B]: Plays an essential role in the virus CC replication cycle by acting as a viroporin. Creates a pore in the host CC reticulum endoplasmic and as a consequence releases Ca2+ in the CC cytoplasm of infected cell. In turn, high levels of cytoplasmic calcium CC may trigger membrane trafficking and transport of viral ER-associated CC proteins to viroplasms, sites of viral genome replication. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 2C]: Associates with and induces structural CC rearrangements of intracellular membranes. Triggers host autophagy by CC interacting with host BECN1 and thereby promotes viral replication. CC Participates in viral replication and interacts with host DHX9. CC Displays RNA-binding, nucleotide binding and NTPase activities. May CC play a role in virion morphogenesis and viral RNA encapsidation by CC interacting with the capsid protein VP3. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 3A]: Plays important roles in virus replication, CC virulence and host range. Cooperates with host DDX56 to inhibit IRF3 CC nuclear translocation and subsequent type I interferon production. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 3B-1]: Covalently linked to the 5'-end of both the CC positive-strand and negative-strand genomic RNAs. Acts as a genome- CC linked replication primer. {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 3B-2]: Covalently linked to the 5'-end of both the CC positive-strand and negative-strand genomic RNAs. Acts as a genome- CC linked replication primer. {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protein 3B-3]: Covalently linked to the 5'-end of both the CC positive-strand and negative-strand genomic RNAs. Acts as a genome- CC linked replication primer. {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: [Protease 3C]: Cysteine protease that generates mature viral CC proteins from the precursor polyprotein. In addition to its proteolytic CC activity, binds to viral RNA and thus influences viral genome CC replication. RNA and substrate bind cooperatively to the protease. CC {ECO:0000250|UniProtKB:P03305}. CC -!- FUNCTION: RNA-directed RNA polymerase 3D-POL replicates genomic and CC antigenomic RNA by recognizing replications specific signals. CC Covalently attaches UMP to a tyrosine of VPg, which is used to prime CC RNA synthesis. The positive stranded RNA genome is first replicated at CC virus induced membranous vesicles, creating a dsRNA genomic replication CC form. This dsRNA is then used as template to synthesize positive CC stranded RNA genomes. ss(+)RNA genomes are either translated, CC replicated or encapsidated. {ECO:0000250|UniProtKB:P03305}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Autocatalytically cleaves itself from the polyprotein of the CC foot-and-mouth disease virus by hydrolysis of a Lys-|-Gly bond, but CC then cleaves host cell initiation factor eIF-4G at bonds -Gly-|- CC Arg- and -Lys-|-Arg-.; EC=3.4.22.46; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + CC RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA- CC COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395; CC EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'- CC diphosphate + H(+) + phosphate; Xref=Rhea:RHEA:23680, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57930, ChEBI:CHEBI:61557; EC=3.6.1.15; CC -!- CATALYTIC ACTIVITY: CC Reaction=Selective cleavage of Gln-|-Gly bond in the poliovirus CC polyprotein. In other picornavirus reactions Glu may be substituted CC for Gln, and Ser or Thr for Gly.; EC=3.4.22.28; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU01222}; CC -!- SUBUNIT: [Leader protease]: Interacts with host ISG15. Capsid protein CC VP1: Interacts (via R-G-D motif) with host ITGAV/ITGB6. Interacts with CC host MAVS; this interaction inhibits binding of host TRAF3 to MAVS, CC thereby suppressing interferon-mediated responses. CC {ECO:0000250|UniProtKB:P03305}. CC -!- SUBUNIT: [Protein 2B]: Forms homooligomers. CC {ECO:0000250|UniProtKB:P03305}. CC -!- SUBUNIT: [Protein 2C]: Interacts with host VIM. Interacts with host CC BECN1. {ECO:0000250|UniProtKB:P03305}. CC -!- SUBUNIT: [Protein 3A]: Interacts with host DCTN3. CC {ECO:0000250|UniProtKB:P03305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein VP2]: Virion. Host cytoplasm CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein VP3]: Virion. Host cytoplasm CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein VP1]: Virion. Host cytoplasm CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Protein 2B]: Host cytoplasmic vesicle membrane CC {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic CC side {ECO:0000305}. Note=Probably localizes to the surface of CC intracellular membrane vesicles that are induced after virus infection CC as the site for viral RNA replication. These vesicles are derived from CC the endoplasmic reticulum (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Protein 2C]: Host cytoplasmic vesicle membrane CC {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic CC side {ECO:0000305}. Note=Probably localizes to the surface of CC intracellular membrane vesicles that are induced after virus infection CC as the site for viral RNA replication. These vesicles are derived from CC the endoplasmic reticulum (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Protein 3A]: Host cytoplasmic vesicle membrane CC {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic CC side {ECO:0000305}. Note=Probably localizes to the surface of CC intracellular membrane vesicles that are induced after virus infection CC as the site for viral RNA replication. These vesicles are derived from CC the endoplasmic reticulum (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: [Protein 3B-1]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Protein 3B-2]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Protein 3B-3]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Protease 3C]: Host cytoplasm {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [RNA-directed RNA polymerase 3D-POL]: Host CC cytoplasmic vesicle membrane {ECO:0000305}; Peripheral membrane protein CC {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Note=Probably localizes CC to the surface of intracellular membrane vesicles that are induced CC after virus infection as the site for viral RNA replication. These CC vesicles are derived from the endoplasmic reticulum (By similarity). CC {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative initiation; Named isoforms=2; CC Name=Lab; CC IsoId=P15072-1; Sequence=Displayed; CC Name=Lb; CC IsoId=P15072-2; Sequence=VSP_018983; CC -!- PTM: Protein 3B-1, 3B-2 and 3B-3 are uridylylated by the polymerase and CC are covalently linked to the 5'-end of genomic RNA. These uridylylated CC forms act as a nucleotide-peptide primer for the polymerase (By CC similarity). {ECO:0000250}. CC -!- PTM: Specific enzymatic cleavages in vivo by the viral proteases yield CC a variety of precursors and mature proteins. Polyprotein processing CC intermediates such as VP0 which is a VP4-VP2 precursor are produced. CC During virion maturation, non-infectious particles are rendered CC infectious following cleavage of VP0. This maturation cleavage is CC followed by a conformational change of the particle. The polyprotein CC seems to be cotranslationally cleaved at the 2A/2B junction by a CC ribosomal skip from one codon to the next without formation of a CC peptide bond. This process would release the L-P1-2A peptide from the CC translational complex (By similarity). {ECO:0000250}. CC -!- PTM: Myristoylation of VP4 is required during RNA encapsidation and CC formation of the mature virus particle. {ECO:0000250}. CC -!- MISCELLANEOUS: The capsid protein VP1 contains the main antigenic CC determinants of the virion; therefore, changes in its sequence must be CC responsible for the high antigenic variability of the virus. CC -!- SIMILARITY: Belongs to the picornaviruses polyprotein family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral capsid CC structure; CC URL="https://viperdb.scripps.edu/Info_Page.php?VDB=1fmd"; CC -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral capsid CC structure in complex with a fab fragment of a neutralizing antibody; CC URL="https://viperdb.scripps.edu/Info_Page.php?VDB=1qgc"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY593805; AAT01748.1; -; Genomic_RNA. DR EMBL; X00130; CAA24960.2; -; Genomic_RNA. DR PIR; A20288; GNNYC1. DR PDB; 1EJO; X-ray; 2.30 A; P=859-873. DR PDB; 1FMD; X-ray; 3.50 A; 2=287-504, 3=505-723. DR PDB; 1QGC; EM; 30.00 A; 2=287-504, 3=505-723. DR PDBsum; 1EJO; -. DR PDBsum; 1FMD; -. DR PDBsum; 1QGC; -. DR SMR; P15072; -. DR MEROPS; C03.008; -. DR MEROPS; C28.001; -. DR ABCD; P15072; 1 sequenced antibody. DR EvolutionaryTrace; P15072; -. DR Proteomes; UP000012671; Genome. DR GO; GO:0044162; C:host cell cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW. DR GO; GO:0039618; C:T=pseudo3 icosahedral viral capsid; IEA:UniProtKB-KW. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:UniProtKB-EC. DR GO; GO:0005216; F:monoatomic ion channel activity; IEA:UniProtKB-KW. DR GO; GO:0017111; F:ribonucleoside triphosphate phosphatase activity; IEA:UniProtKB-EC. DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW. DR GO; GO:0003724; F:RNA helicase activity; IEA:InterPro. DR GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW. DR GO; GO:0005198; F:structural molecule activity; IEA:InterPro. DR GO; GO:0075512; P:clathrin-dependent endocytosis of virus by host cell; IEA:UniProtKB-KW. DR GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro. DR GO; GO:0039520; P:induction by virus of host autophagy; ISS:UniProtKB. DR GO; GO:0039525; P:modulation by virus of host chromatin organization; IEA:UniProtKB-KW. DR GO; GO:0051259; P:protein complex oligomerization; IEA:UniProtKB-KW. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW. DR GO; GO:0019082; P:viral protein processing; IEA:InterPro. DR GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro. DR GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW. DR GO; GO:0039707; P:virus-mediated pore formation in host cell membrane; IEA:UniProtKB-KW. DR CDD; cd23210; Aphthovirus_RdRp; 1. DR CDD; cd00205; rhv_like; 3. DR Gene3D; 1.20.960.20; -; 1. DR Gene3D; 2.60.120.20; -; 3. DR Gene3D; 3.30.70.270; -; 2. DR Gene3D; 4.10.90.10; Capsid protein VP4 superfamily, Picornavirus; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 1. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2. DR InterPro; IPR015031; Capsid_VP4_Picornavir. DR InterPro; IPR037080; Capsid_VP4_sf_Picornavirus. DR InterPro; IPR043502; DNA/RNA_pol_sf. DR InterPro; IPR004080; FMDV_VP1_coat. DR InterPro; IPR004004; Helic/Pol/Pept_Calicivir-typ. DR InterPro; IPR000605; Helicase_SF3_ssDNA/RNA_vir. DR InterPro; IPR014759; Helicase_SF3_ssRNA_vir. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR044067; PCV_3C_PRO. DR InterPro; IPR008739; Peptidase_C28. DR InterPro; IPR000199; Peptidase_C3A/C3B_picornavir. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin. DR InterPro; IPR001676; Picornavirus_capsid. DR InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase. DR InterPro; IPR033703; Rhv-like. DR InterPro; IPR001205; RNA-dir_pol_C. DR InterPro; IPR007094; RNA-dir_pol_PSvirus. DR InterPro; IPR029053; Viral_coat. DR Pfam; PF05408; Peptidase_C28; 1. DR Pfam; PF00548; Peptidase_C3; 1. DR Pfam; PF00680; RdRP_1; 1. DR Pfam; PF00073; Rhv; 3. DR Pfam; PF00910; RNA_helicase; 1. DR Pfam; PF08935; VP4_2; 1. DR PRINTS; PR00918; CALICVIRUSNS. DR PRINTS; PR01542; FMDVP1COAT. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF56672; DNA/RNA polymerases; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR SUPFAM; SSF88633; Positive stranded ssRNA viruses; 2. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS51887; APHTHOVIRUS_LPRO; 1. DR PROSITE; PS51874; PCV_3C_PRO; 1. DR PROSITE; PS50507; RDRP_SSRNA_POS; 1. DR PROSITE; PS51218; SF3_HELICASE_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative initiation; ATP-binding; Capsid protein; KW Clathrin- and caveolin-independent endocytosis of virus by host; KW Clathrin-mediated endocytosis of virus by host; KW Covalent protein-RNA linkage; Disulfide bond; Helicase; Host cytoplasm; KW Host cytoplasmic vesicle; Host membrane; Host-virus interaction; Hydrolase; KW Ion channel; Ion transport; Lipoprotein; Membrane; KW Modulation of host chromatin by virus; Myristate; Nucleotide-binding; KW Nucleotidyltransferase; Phosphoprotein; Protease; RNA-binding; KW RNA-directed RNA polymerase; T=pseudo3 icosahedral capsid protein; KW Thiol protease; Transferase; Translation regulation; Transport; KW Viral attachment to host cell; Viral ion channel; KW Viral penetration into host cytoplasm; Viral RNA replication; Virion; KW Virus endocytosis by host; Virus entry into host cell. FT CHAIN 1..2327 FT /note="Genome polyprotein" FT /evidence="ECO:0000250" FT /id="PRO_0000039891" FT CHAIN 1..201 FT /note="Leader protease" FT /id="PRO_0000039892" FT CHAIN 202..504 FT /note="Capsid protein VP0" FT /evidence="ECO:0000255" FT /id="PRO_0000374077" FT CHAIN 202..286 FT /note="Capsid protein VP4" FT /evidence="ECO:0000255" FT /id="PRO_0000039895" FT CHAIN 287..504 FT /note="Capsid protein VP2" FT /evidence="ECO:0000255" FT /id="PRO_0000039896" FT CHAIN 505..723 FT /note="Capsid protein VP3" FT /evidence="ECO:0000255" FT /id="PRO_0000039897" FT CHAIN 724..930 FT /note="Capsid protein VP1" FT /evidence="ECO:0000255" FT /id="PRO_0000039898" FT CHAIN 931..948 FT /note="Protein 2A" FT /evidence="ECO:0000255" FT /id="PRO_0000039899" FT CHAIN 949..1102 FT /note="Protein 2B" FT /evidence="ECO:0000255" FT /id="PRO_0000310980" FT CHAIN 1103..1420 FT /note="Protein 2C" FT /evidence="ECO:0000255" FT /id="PRO_0000422519" FT CHAIN 1421..1573 FT /note="Protein 3A" FT /evidence="ECO:0000255" FT /id="PRO_0000422520" FT CHAIN 1574..1596 FT /note="Protein 3B-1" FT /evidence="ECO:0000255" FT /id="PRO_0000422521" FT CHAIN 1597..1620 FT /note="Protein 3B-2" FT /evidence="ECO:0000255" FT /id="PRO_0000422522" FT CHAIN 1621..1644 FT /note="Protein 3B-3" FT /evidence="ECO:0000255" FT /id="PRO_0000422523" FT CHAIN 1645..1857 FT /note="Protease 3C" FT /evidence="ECO:0000255" FT /id="PRO_0000422524" FT CHAIN 1858..2327 FT /note="RNA-directed RNA polymerase 3D-POL" FT /evidence="ECO:0000255" FT /id="PRO_0000422525" FT TOPO_DOM 1..1475 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT INTRAMEM 1476..1496 FT /evidence="ECO:0000255" FT TOPO_DOM 1497..2327 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 1..201 FT /note="Peptidase C28" FT DOMAIN 1184..1348 FT /note="SF3 helicase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00551" FT DOMAIN 1647..1843 FT /note="Peptidase C3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01222" FT DOMAIN 2091..2209 FT /note="RdRp catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00539" FT REGION 199..218 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 237..265 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1524..1579 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 864..866 FT /note="Cell attachment site" FT COMPBIAS 200..218 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 51 FT /note="For leader protease activity" FT /evidence="ECO:0000250" FT ACT_SITE 148 FT /note="For leader protease activity" FT /evidence="ECO:0000250" FT ACT_SITE 163 FT /note="For leader protease activity" FT /evidence="ECO:0000250" FT ACT_SITE 1690 FT /note="For protease 3C activity; Proton donor/acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01222" FT ACT_SITE 1728 FT /note="For protease 3C activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01222" FT ACT_SITE 1807 FT /note="For protease 3C activity" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01222" FT ACT_SITE 2195 FT /note="For RdRp activity" FT /evidence="ECO:0000250|UniProtKB:P12296" FT BINDING 1212..1219 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00551" FT SITE 201..202 FT /note="Cleavage; by leader protease" FT /evidence="ECO:0000255" FT SITE 286..287 FT /note="Cleavage" FT /evidence="ECO:0000255" FT SITE 504..505 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 723..724 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 930..931 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 948..949 FT /note="Cleavage; by ribosomal skip" FT /evidence="ECO:0000255" FT SITE 1102..1103 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1420..1421 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1573..1574 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1596..1597 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1620..1621 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1644..1645 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT SITE 1857..1858 FT /note="Cleavage; by picornain 3C" FT /evidence="ECO:0000255" FT MOD_RES 1576 FT /note="O-(5'-phospho-RNA)-tyrosine" FT /evidence="ECO:0000250" FT MOD_RES 1599 FT /note="O-(5'-phospho-RNA)-tyrosine" FT /evidence="ECO:0000250" FT MOD_RES 1623 FT /note="O-(5'-phospho-RNA)-tyrosine" FT /evidence="ECO:0000250" FT LIPID 202 FT /note="N-myristoyl glycine; by host" FT /evidence="ECO:0000250" FT DISULFID 511 FT /note="Interchain; in VP3 dimer" FT /evidence="ECO:0000250" FT VAR_SEQ 1..28 FT /note="Missing (in isoform Lb)" FT /evidence="ECO:0000305" FT /id="VSP_018983" FT VARIANT 8 FT /note="I -> T" FT VARIANT 48 FT /note="H -> Q" FT VARIANT 307 FT /note="H -> Q" FT VARIANT 408..409 FT /note="LV -> QA" FT VARIANT 726 FT /note="A -> T" FT VARIANT 852 FT /note="A -> G" FT VARIANT 867 FT /note="S -> L" FT VARIANT 876 FT /note="R -> G" FT STRAND 291..293 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 302..305 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 308..311 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 332..334 FT /evidence="ECO:0007829|PDB:1FMD" FT TURN 342..344 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 348..355 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 364..372 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 375..383 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 384..398 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 404..413 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 421..423 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 429..434 FT /evidence="ECO:0007829|PDB:1FMD" FT TURN 436..438 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 440..446 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 450..455 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 457..459 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 463..474 FT /evidence="ECO:0007829|PDB:1FMD" FT TURN 476..478 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 483..499 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 548..554 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 561..563 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 571..574 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 576..581 FT /evidence="ECO:0007829|PDB:1FMD" FT TURN 587..591 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 593..598 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 601..605 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 608..614 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 621..629 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 631..633 FT /evidence="ECO:0007829|PDB:1FMD" FT HELIX 639..642 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 645..651 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 659..662 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 667..669 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 671..674 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 686..696 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 701..708 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 713..717 FT /evidence="ECO:0007829|PDB:1FMD" FT STRAND 863..865 FT /evidence="ECO:0007829|PDB:1EJO" SQ SEQUENCE 2327 AA; 258119 MW; A81AB150E79617DD CRC64; MNTTDCFIAV VNAIREIRAL FLPRTTGKME FTLHDGEKKV FYSRPNNHDN CWLNTILQLF RYVDEPFFDW VYNSPENLTL EAIKQLEELT GLELREGGPP ALVIWNIKHL LHTGIGTASR PSEVCMVDGT DMCLADFHAG IFMKGQEHAV FACVTSNGWY AIDDEDFYPW TPDPSDVLVF VPYDQEPLNE GWKANVQRKL KGAGQSSPAT GSQNQSGNTG SIINNYYMQQ YQNSMDTQLG DNAISGGSNE GSTDTTSTHT TNTQNNDWFS KLASSAFSGL FGALLADKKT EETTLLEDRI LTTRNGHTTS TTQSSVGVTF GYATAEDSTS GPNTSGLETR VHQAERFFKM ALFDWVPSQN FGHMHKVVLP HEPKGVYGGL VKSYAYMRNG WDVEVTAVGN QFNGGCLLVA LVPEMGDISD REKYQLTLYP HQFINPRTNM TAHITVPYVG VNRYDQYKQH RPWTLVVMVV APLTTNTAGA QQIKVYANIA PTNVHVAGEL PSKEGIFPVA CSDGYGNMVT TDPKTADPAY GKVYNPPRTA LPGRFTNYLD VAEACPTFLM FENVPYVSTR TDGQRLLAKF DVSLAAKHMS NTYLAGLAQY YTQYTGTINL HFMFTGPTDA KARYMVAYVP PGMDAPDNPE EAAHCIHAEW DTGLNSKFTF SIPYISAADY AYTASHEAET TCVQGWVCVY QITHGKADAD ALVVSASAGK DFELRLPVDA RQQTTATGES ADPVTTTVEN YGGETQVQRR HHTDVAFVLD RFVKVTVSGN QHTLDVMQAH KDNIVGALLR AATYYFSDLE IAVTHTGKLT WVPNGAPVSA LDNTTNPTAY HKGPLTRLAL PYTAPHRVLA TAYTGTTTYT ASTRGDSAHL TATRARHLPT SFNFGAVKAE TITELLVRMK RAELYCPRPI LPIQPTGDRH KQPLVAPAKQ LLNFDLLKLA GDVESNPGPF FFSDVRSNFS KLVETINQMQ EDMSTKHGPD FNRLVSAFEE LASGVKAIRT GLDEAKPWYK LIKLLSRLSC MAAVAARSKD PVLVAIMLAD TGLEILDSTF VVKKISDSLS SLFHVPAPAF SFGAPILLAG LVKVASSFFR STPEDLERAE KQLKARDIND IFAILKNGEW LVKLILAIRD WIKAWIASEE KFVTMTDLVP GILEKQRDLN DPSKYKDAKE WLDNTRQACL KSGNVHIANL CKVVAPAPSK SRPEPVVVCL RGKSGQGKSF LANVLAQAIS THLTGRTDSV WYCPPDPDHF DGYNQQTVVV MDDLGQNPDG KDFKYFAQMV STTGFIPPMA SLEDKGKPFS SKVIIATTNL YSGFTPKTMV CPDALNRRFH FDIDVSAKDG YKINNKLDII KALEDTHTNP VAMFQYDCAL LNGMAVEMKR LQQDMFKPQP PLQNVYQLVQ EVIERVELHE KVSSHPIFKQ ISIPSQKSVL YFLIEKGQHE AAIEFFEGMV HDSIKEELRP LIQQTSFVKR AFKRLKENFE IVALCLTLLA NIVIMIRETH KRQKMVDDAV NEYIEKANIT TDDKTLDEAE KNPLETSGAS TVGFRERTLP GQKARDDVNS EPAQPTEEQP QAEGPYAGPL ERQRPLKVRA KLPQQEGPYA GPMERQKPLK VKARAPVVKE GPYEGPVKKP VALKVKAKNL IVTESGAPPT DLQKMVMGNT KPVELILDGK TVAICCATGV FGTAYLVPRH LFAEKYDKIM LDGRALTDSD YRVFEFEIKV KGQDMLSDAA LMVLHRGNRV RDITKHFRDV ARMKKGTPVV GVINNADVGR LIFSGEALTY KDIVVCMDGD TMPGLFAYKA ATKAGYCGGA VLAKDGADTF IVGTHSAGGN GVGYCSCVSR SMLLKMKAHI DPEPHHEGLI VDTRDVEERV HVMRKTKLAP TVAHGVFNPE FGPAALSNKD PRLNEGVVLD EVIFSKHKGD TKMSEEDKAL FRRCAADYAS RLHSVLGTAN APLSIYEAIK GVDGLDAMEP DTAPGLPWAL QGKRRGALID FENGTVGPEV EAALKLMEKR EYKFACQTFL KDEIRPMEKV RAGKTRIVDV LPVEHILYTR MMIGRFCAQM HSNNGPQIGS AVGCNPDVDW QRFGTHFAQY RNVWDVDYSA FDANHCSDAM NIMFEEVFRT EFGFHPNAEW ILKTLVNTEH AYENKRITVE GGMPSGCSAT SIINTILNNI YVLYALRRHY EGVELDTYTM ISYGDDIVVA SDYDLDFEAL KPHFKSLGQT ITPADKSDKG FVLGHSITDV TFLKRHFHMD YGTGFYKPVM ASKTLEAILS FARRGTIQEK LISVAGLAVH SGPDEYRRLF EPFQGLFEIP SYRSLYLRWV NAVCGDA //